ON TARGET LABORATORIES

on-target-laboratories-logo

On Target Laboratories, LLC engages in discovering, developing, and commercializing small molecules that target specific pathological cells, when conjugated with fluorescent dyes. It offers folate and other targeting agents that target, lung, uterine, kidney, breast, colon, pancreatic, and prostate cancer cells. The company was incorporated in 2010 and is based in Northbrook, Illinois.

#SimilarOrganizations #People #Financial #Website #More

ON TARGET LABORATORIES

Social Links:

Industry:
Biotechnology Life Science Medical

Founded:
2010-01-01

Address:
Northbrook, Illinois, United States

Country:
United States

Website Url:
http://www.ontargetlabs.com

Total Employee:
51+

Status:
Active

Contact:
6105846191

Total Funding:
81.7 M USD

Technology used in webpage:
Google Apps For Business Google Maps Google Google Maps API Google Cloud WP Engine Register.com DNS


Similar Organizations

editas-medicine-logo

Editas Medicine

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.


Current Advisors List

bernie-haffey_image

Bernie Haffey Board Member @ On Target Laboratories
Board_member
2019-12-01

Current Employees Featured

philip-low_image

Philip Low
Philip Low Co-Founder & Chief Science Officer @ On Target Laboratories
Co-Founder & Chief Science Officer
2011-01-01

tim-biro_image

Tim Biro
Tim Biro COO @ On Target Laboratories
COO

martin-low_image

Martin Low
Martin Low CEO @ On Target Laboratories
CEO

Founder


philip-low_image

Philip Low

Investors List

helsinn-investment-fund_image

3B Future Health Fund

3B Future Health Fund investment in Series B - On Target Laboratories

hig-capital_image

H.I.G. Capital

H.I.G. Capital investment in Series B - On Target Laboratories

johnson-johnson-innovation_image

Johnson & Johnson Innovation

Johnson & Johnson Innovation investment in Series B - On Target Laboratories

elevate-ventures_image

Elevate Ventures

Elevate Ventures investment in Series B - On Target Laboratories

elevate-ventures_image

Elevate Ventures

Elevate Ventures investment in Series B - On Target Laboratories

helsinn-investment-fund_image

3B Future Health Fund

3B Future Health Fund investment in Series B - On Target Laboratories

h-i-g-biohealth-partners_image

H.I.G. BioHealth Partners

H.I.G. BioHealth Partners investment in Series B - On Target Laboratories

johnson-johnson-innovation-jjdc_image

Johnson & Johnson Innovation โ€“ JJDC

Johnson & Johnson Innovation โ€“ JJDC investment in Series B - On Target Laboratories

foundry-investment-fund-of-indiana_image

Purdue Foundry Investment Fund

Purdue Foundry Investment Fund investment in Venture Round - On Target Laboratories

tom-hurvis_image

Tom Hurvis

Tom Hurvis investment in Venture Round - On Target Laboratories

Official Site Inspections

http://www.ontargetlabs.com

  • Host name: 172.67.208.238
  • IP address: 172.67.208.238
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "On Target Laboratories"

About On Target Laboratories

On Target Laboratories develops technologies which enable surgeons to remove more cancer during surgery. Since On Targetโ€™s founding in 2010, our team of researchers and scientists โ€ฆSee details»

On Target Laboratories - Crunchbase Company Profile & Funding

On Target Laboratories may be growing as it has secured a significant amount of funding, specifically $30 million, to advance the commercialization of a new cancer imaging agent.See details»

On Target Laboratories - LinkedIn

On Target Laboratories discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery so cancerous tissue can be removed more completely. To date ...See details»

On Target Laboratories Appoints Bill Peters as CEO

Dec 10, 2024 On Target Laboratories, Inc., a leading biotechnology company specializing in the development of intraoperative molecular imaging agents to target and illuminate cancer during surgery, today ...See details»

On Target Laboratories - Products, Competitors, Financials, โ€ฆ

08:00 ET On Target Laboratories Appoints Bill Peters as CEO. Dec 10, 2024. News provided by Share this article Share toX WEST LAFAYETTE, Ind., Dec. 10, 2024 /PRNewswire/ -- On โ€ฆSee details»

On Target Laboratories - Craft

On Target Laboratories has 5 employees at their 1 location and $81.7 m in total funding,. See insights on On Target Laboratories including office locations, competitors, revenue, financials, โ€ฆSee details»

On Target Laboratories Names David Liu, M.D, as Chief โ€ฆ

WEST LAFAYETTE, Ind., May 15, 2024 . โ€“ On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, today โ€ฆSee details»

On Target Laboratories LLC - Drug pipelines, Patents ... - Patsnap

Ontargetlabs.com. Holding Company | 2010 | Indiana, United States | ontargetlabs.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The statistics โ€ฆSee details»

On Target - HealthCare and Diagnostics

The professional people behind On Target Healthcare and Diagnostics Inc. ensures business with its professional credo, โ€˜patientโ€™s firstโ€™ โ€“ a product that has been the enhanced through a cumulative experience spanning more than two โ€ฆSee details»

On Target Laboratories CEO and Key Executive Team | Craft.co

On Target Laboratories's Chief Operating Officer is Tim Biro. Other executives include Phil Low, Chief Science Officer; Kathy Ward, Vice President, Finance and 3 others. See the full โ€ฆSee details»

Science - On Target Laboratories

Featured Publications Lung Cancer Phase 3 Study (ELUCIDATE) Multi-Institutional Phase 2 Clinical Trial of Intraoperative Molecular Imaging of Lung Cancer Annals of Thoracic Surgery, โ€ฆSee details»

On Target Laboratories - Overview, News & Similar companies

On Target Laboratories contact info: Phone number: (765) 588-4547 Website: ontargetlabs.com What does On Target Laboratories do? On Target Laboratories develops technologies which โ€ฆSee details»

On Target Laboratories, Inc. - YouTube

The mission of On Target Laboratories, Inc. is to make cancer visible during surgery so it can be removed more completely. On Target Laboratories discovers and develops fluorescent โ€ฆSee details»

On Target Laboratories - CB Insights

Earlier in his career, he held numerous marketing, sales, international and general management positions for Eli Lillyโ€™s Medical Device Division and Guidant. Mr. French currently serves on the โ€ฆSee details»

On Target Laboratories Awarded โ€œMost Innovative Product of the โ€ฆ

A single dose of the agent is administered via intravenous infusion prior to surgery and assists surgeons in visually identifying additional cancerous tissue to be removed during the โ€ฆSee details»

About On Target Laboratories - H.I.G. BioHealth Partners

WEST LAFAYETTE, IN โ€“ November 16, 2023 โ€“ On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and โ€ฆSee details»

On Target Laboratories Secures $30M for New Cancer Imaging โ€ฆ

Jan 14, 2024 On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, โ€ฆSee details»

News from On Target Laboratories

Aug 12, 2015 February 19, 2025 On Target Laboratories Awarded โ€œMost Innovative Product of the Yearโ€ by Best in Biz Read More February 13, 2025 On Target Cancer Innovation Featured โ€ฆSee details»

On Target Cancer Innovation Featured in Two Journal Articles

A single dose of the agent is administered via intravenous infusion prior to surgery and assists surgeons in visually identifying additional cancerous tissue to be removed during the โ€ฆSee details»

linkstock.net © 2022. All rights reserved